Double digit growth | Stonking Small Cap updates
Our coverage here includes a review of stunning results from a manufacturer of products for the aerospace sector. While the current year will see growth stall, with plenty of investment and an expanding market opportunity, the future continues to look extremely exciting for this small company. Elsewhere, a manufacturer of infection prevention products is also doing nicely, as are two of our Stonking Small Cap opportunities.
Tristel: double digit growth Tristel (AIM: TSTL), the manufacturer of infection prevention products, delivered another year of strong growth, including encouraging progress in the key US market. Tristel continues to see strong demand for its infection prevention products, with second half revenues increasing by 15% on a constant currency basis and revenues for the full year to 30 June 2025 up 11% to £46.5m. That’s in line with the Company's performance target for annual revenue growth averaging 10-15% over three years. Adjusted profit before tax is expected to be no less than £10.1m, in line with expectations and 23% up…